# New JAK City, PE Exit Struggles, CBD for Dogs Inches Forward, PetcoLove 4M Page: https://stenobird.com/podcast/the-bird-bath-6464778/new-jak-city-pe-exit-struggles-cbd-for-dogs-inches-forward-petcolove-4m Text version: https://stenobird.com/podcast/the-bird-bath-6464778/new-jak-city-pe-exit-struggles-cbd-for-dogs-inches-forward-petcolove-4m.md Podcast: [The Bird Bath](https://stenobird.com/podcast/the-bird-bath-6464778) Published: 2026-03-10T14:00:02+00:00 Episode link: https://share.transistor.fm/s/8578a0a5 Audio file: https://media.transistor.fm/8578a0a5/a810d3e3.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/the-bird-bath-6464778/episodes/new-jak-city-pe-exit-struggles-cbd-for-dogs-inches-forward-petcolove-4m Duration seconds: 751 ## Resource Second week of March, what'd you miss in vet med? FDA approves Merck's NUMELVI — first second-gen JAK inhibitor for dogs PE firms struggling to exit pandemic-era vet deals (Encore, CareVet, and Blue River hit the market) InnoCan gets third FDA fee waiver for CBD pain injection in dogs PetSmart + Healthy Paws expand insurance partnership Petco Love hits 4 million free vaccines Helpful links: The Bird Bath substack VRCE - The Veterinary Profession’s #1 CSR Development Program 2026 Animal Health Summit Emerging Company Application TikTok - Is it Pet Smart or Pets Marks? ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bird-bath-6464778/episodes/new-jak-city-pe-exit-struggles-cbd-for-dogs-inches-forward-petcolove-4m/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/the-bird-bath-6464778/new-jak-city-pe-exit-struggles-cbd-for-dogs-inches-forward-petcolove-4m.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.